Delivery Order SPE2DX22D0040-SPE2D826FA3RU
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,483.30 delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract executed through the company's existing Indefinite Delivery Contract (IDC) with Defense Logistics Agency Troop Support Medical. The place of performance is...
- The U.S. Department of Defense Medical Supply Chain awarded a $25,525.44 firm fixed-price delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., on January 19, 2026, with an ultimate completion date of January 20, 2026. This non-set-aside contract was competitively awarded and is being performed in Conshohocken, Pennsylvania, where AmerSourceBergen's corporate office is located. The delivery order represents a task order issued under a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $26,646.24 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), headquartered in Conshohocken, Pennsylvania, on January 19, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was competitively awarded with no set-aside designation. AmerSourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- On January 14, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,651.68 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of January 15, 2026, was competitively awarded with no set-aside designation. AmerSourceBergen Drug Corp operates as a child entity of Cencora, Inc. (doing business as...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $33,375.58 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 12, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion on January 13, 2026 and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerSourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $55,148.55 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), headquartered in Conshohocken, Pennsylvania, on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $32,134.20 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which received no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $26,681.96 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 19, 2026, with completion expected by January 20, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerSourceBergen's parent company Cencora, Inc. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania....
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $79,347.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a performance location in Conshohocken, Pennsylvania. This firm fixed-price delivery order, which is set to complete by January 20, 2026, represents a child contract action under the parent company Cencora, Inc. (doing business as AmerSourceBergen). The award was made on a fully competitive, non-set-aside basis,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,203.89 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. The contract, awarded on January 6, 2026, utilizes a firm fixed-price structure with an ultimate completion date of January 7, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- SPE2DX22D0040Indefinite Delivery Contract
- SPE2DX22D0040-SPE2D826FA3RUDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a $34,994.33 firm fixed-price delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), headquartered in Conshohocken, Pennsylvania, on January 19, 2026, with an ultimate completion date of January 20, 2026. This delivery order represents a child contract issued under a larger Indefinite Delivery Contract (IDC) vehicle—the Defense Logistics Agency Troop Support Medical Prime Vendor Global Program contract valued at $999,999,999.00 through December 2026. The award is unset-aside and was competitively awarded, reflecting AmerSourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The company serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran healthcare systems, supplying a comprehensive range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. AmerSourceBergen Drug Corp is a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), which operates under the doing-business-as name AmerSourceBergen. Cencora holds the primary $999,999,999.00 IDC with the Defense Logistics Agency through December 31, 2031, serving as the overarching vehicle for pharmaceutical supply to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The Defense Logistics Agency is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerSourceBergen to continue serving defense healthcare customers including the Defense Health Agency and U.S. Coast Guard through flexible and comprehensive contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 1/18/26 |